Global L-Carnitine Market Size by Application (Animal Feed, Healthcare Products), by Product Outlook (Food Grade), by Process Outlook (Chemical Synthesis) & Region - Key Manufacturers, Analysis, Growth Trends, and Forecast till 2026

  • Category : Healthcare and Pharma
  • |
  • ID : 1332035
  • |
  • Date : October 2019
  • |
  • No of Pages: 121
  • |
  • Publisher : Intellectual Research Partners

L-carnitine is known to enhance post-exercise recovery among the elderly. It also helps in reducing fatigue and boosting mental functioning. Moreover, it minimizes the risk of skeletal decline, which is common among the aging population. The product is beneficial in maintaining lean muscle mass, reducing muscle degradation, and promoting healthy aging.

The Global L-Carnitine Market was estimated to be valued at USD XX million in 2018 and is projected to reach USD XX million by 2026, at a CAGR of XX% during 2019 to 2026. Growing health concerns among the geriatric population along with increasing consumer inclination toward preventive healthcare the market growth. However, alternative supplement availability in the market might become barrier to the market growth in the forecast period.

The global L-carnitine market is primarily segmented based on different application, process outlook, product outlook and region. On the basis application, market is segmented into animal feed and healthcare products, functional drinks and medicines and other application. . On the basis of process outlook, market is segmented into chemical synthesis and bioprocess. On the basis of product outlook, market is segmented into food grade, pharmaceutical grade and feed grade On the basis of regions, market is segmented into North America, Europe, Asia-Pacific, South America, and Middle East & Africa.

On the basis of application, the market is split into:
* Animal Feed
* Healthcare Products
* Functional Drinks
* Medicines
* Other Application

On the basis of process outlook, the market is split into:
* Chemical Synthesis
* Bioprocess

On the basis of product outlook, the market is split into:
* Food Grade
* Pharmaceutical Grade
* Feed Grade

Moreover, the market is classified based on regions and countries as follows:
* North America- U.S., Canada
* Europe- U.K., France, Germany, Italy and Rest of Europe
* Asia-Pacific- China, Japan, India and Rest of Asia Pacific
* South America- Brazil, Mexico and Rest of South America
* Middle East & Africa- South Africa, Saudi Arabia and Rest of Middle East & Africa

Key Market Players:
The key players profiled in the market include:
* Lonza Group Ltd.
* Northeast Pharmaceutical Group Co.
* Biosint S.p.A.
* Cayman Chemical
* NovaDel Pharma Inc.
* NovaDel Pharma Inc.
* Merck KGaA
* Tokyo Chemical Industry Co.
* Ceva Santé Animale S.A.
* Kaiyuan Hengtai Chemical Co., Ltd.

These enterprises are focusing on growth strategies, such as new product launches, expansions, acquisitions, and agreements & partnerships to expand their operations across the globe.

Key Benefits of the Report:
* Global, regional, country, application, product outlook, process outlook market size and their forecast from 2018-2026
* Identification and detailed analysis on key market dynamics, such as, drivers, restraints, opportunities, and challenges influencing growth of the market
* Detailed analysis on industry outlook with market specific PESTLE, and supply chain to better understand the market and build expansion strategies
* Identification of key market players and comprehensively analyze their market share and core competencies, detailed financial positions, key products, and unique selling points
* Analysis on key players’ strategic initiatives and competitive developments, such as joint ventures, mergers, and new product launches in the market
* Expert interviews and their insights on market shift, current and future outlook, and factors impacting vendors’ short term and long term strategies
* Detailed insights on emerging regions application, process outlook and product outlook with qualitative and quantitative production and facts

Target Audience:
* L-Carnitine Manufactures
* Traders, Importers, and Exporters
* Raw Material Suppliers and Distributors
* Research and Consulting Firms
* Government and Research Organizations
* Associations and Industry Bodies

Research Methodology:
The market is derived through extensive use of secondary, primary, in-house research follows by expert validation and third party perspective, such as, analyst reports of investment banks. The secondary research is the primary base of our study wherein we conducted extensive data mining, referring to verified data products, such as, white papers, government and regulatory published articles, technical journals, trade magazines, and paid data products.

For forecasting, regional demand & supply factors, recent investments, market dynamics including technical growth scenario, consumer behavior, and end use trends and dynamics, and production capacity were taken into consideration. Different weightages have been assigned to these parameters and quantified their market impacts using the weighted average analysis to derive the market growth rate.

The market estimates and forecasts have been verified through exhaustive primary research with the Key Industry Participants (KIPs), which typically include:
* Manufacturers
* Suppliers
* Distributors
* Government Body & Associations
* Research Institutes

TABLE OF CONTENTS

1. Introduction

2. Research Methodology

3. Executive Summary

4. Global L-Carnitine Market Overview
4.1. Market Segmentation & Scope
4.2. Market Trends
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.2.4. Supply Chain Analysis
4.3. Global L-Carnitine Market - Porter\'s Five Forces Analysis
4.4. Global L-Carnitine Market - PESTEL Analysis

5. Global L-Carnitine Market, by Application
5.1. Global L-Carnitine Market, Size and Forecast, 2015-2026
5.2. Global L-Carnitine Market, by Animal Feed, 2015-2026
5.2.1. Key driving factors, trends and opportunities
5.2.2. Market size and forecast, 2015-2026
5.3. Global L-Carnitine Market, by Healthcare Products, 2015-2026
5.3.1. Key driving factors, trends and opportunities
5.3.2. Market size and forecast, 2015-2026
5.4. Global L-Carnitine Market, by Functional Drinks, 2015-2026
5.4.1. Key driving factors, trends and opportunities
5.4.2. Market size and forecast, 2015-2026
5.5. Global L-Carnitine Market, by Medicines, 2015-2026
5.5.1. Key driving factors, trends and opportunities
5.5.2. Market size and forecast, 2015-2026
5.6. Global L-Carnitine Market, by Other Application, 2015-2026
5.6.1. Key driving factors, trends and opportunities
5.6.2. Market size and forecast, 2015-2026

6. Global L-Carnitine Market, by Process Outlook
6.1. Global L-Carnitine Market, Size and Forecast, 2015-2026
6.2. Global L-Carnitine Market, by Chemical Synthesis, 2015-2026
6.2.1. Key driving factors, trends and opportunities
6.2.2. Market size and forecast, 2015-2026
6.3. Global L-Carnitine Market, by Bioprocess, 2015-2026
6.3.1. Key driving factors, trends and opportunities
6.3.2. Market size and forecast, 2015-2026

7. Global L-Carnitine Market, by Product Outlook
7.1. Global L-Carnitine Market, Size and Forecast, 2015-2026
7.2. Global L-Carnitine Market, by Food Grade, 2015-2026
7.2.1. Key driving factors, trends and opportunities
7.2.2. Market size and forecast, 2015-2026
7.3. Global L-Carnitine Market, by Pharmaceutical Grade, 2015-2026
7.3.1. Key driving factors, trends and opportunities
7.3.2. Market size and forecast, 2015-2026
7.4. Global L-Carnitine Market, by Feed Grade, 2015-2026
7.4.1. Key driving factors, trends and opportunities
7.4.2. Market size and forecast, 2015-2026

8. Global L-Carnitine Market by Region
8.1. L-Carnitine Market Regional Analysis, 2015-2026
8.2. Global L-Carnitine Market Revenue (USD Million) by Region, 2015-2026
8.3. North America L-Carnitine Market, 2015-2026
8.3.1. North America L-Carnitine Market Size and Forecast, 2015-2026
8.3.2. North America L-Carnitine Market by Country, 2015-2026
8.3.2.1. U.S. L-Carnitine Market, 2015-2026
8.3.2.2. Canada L-Carnitine Market, 2015-2026
8.4. Europe L-Carnitine Market, 2015-2026
8.4.1. Europe L-Carnitine Market Size and Forecast, 2015-2026
8.4.2. Europe L-Carnitine Market by Country, 2015-2026
8.4.2.1. Germany L-Carnitine Market, 2015-2026
8.4.2.2. France L-Carnitine Market, 2015-2026
8.4.2.3. Italy L-Carnitine Market, 2015-2026
8.4.2.4. UK L-Carnitine Market, 2015-2026
8.4.2.5. Spain L-Carnitine Market, 2015-2026
8.4.2.6. Rest of Europe L-Carnitine Market, 2015-2026
8.5. Asia Pacific L-Carnitine Market, 2015-2026
8.5.1. Asia Pacific L-Carnitine Market Size and Forecast, 2015-2026
8.5.2. Asia Pacific L-Carnitine Market by Country, 2015-2026
8.5.2.1. Japan L-Carnitine Market, 2015-2026
8.5.2.2. China L-Carnitine Market, 2015-2026
8.5.2.3. India L-Carnitine Market, 2015-2026
8.5.2.4. Rest of Asia Pacific L-Carnitine Market, 2015-2026
8.6. South America L-Carnitine Market, 2015-2026
8.6.1. South America L-Carnitine Market Size and Forecast, 2015-2026
8.6.2. South America L-Carnitine Market by Country, 2015-2026
8.6.2.1. Mexico L-Carnitine Market, 2015-2026
8.6.2.2. Brazil L-Carnitine Market, 2015-2026
8.6.2.3. Rest of South America L-Carnitine Market, 2015-2026
8.7. Middle East & Africa L-Carnitine Market, 2015-2026
8.7.1. Middle East & Africa L-Carnitine Market Size and Forecast, 2015-2026
8.7.2. Middle East & Africa L-Carnitine Market by Country, 2015-2026
8.7.2.1. Saudi Arabia L-Carnitine Market, 2015-2026
8.7.2.2. South Africa L-Carnitine Market, 2015-2026
8.7.2.3. Rest of Middle East & Africa L-Carnitine Market, 2015-2026

9. Competitive Landscape
9.1. Introduction
9.2. Market Share Analysis/Top Player Positioning, 2018

10. Company Profiles
10.1. Lonza Group Ltd.
10.1.1. Company Overview
10.1.2. Financial Overview
10.1.3. Product Benchmarking
10.1.4. Key Developments
10.2. Northeast Pharmaceutical Group Co.
10.2.1. Company Overview
10.2.2. Financial Overview
10.2.3. Product Benchmarking
10.2.4. Key Developments
10.3. Biosint S.p.A.
10.3.1. Company Overview
10.3.2. Financial Overview
10.3.3. Product Benchmarking
10.3.4. Key Developments
10.4. Cayman Chemical
10.4.1. Company Overview
10.4.2. Financial Overview
10.4.3. Product Benchmarking
10.4.4. Key Developments
10.5. NovaDel Pharma Inc.
10.5.1. Company Overview
10.5.2. Financial Overview
10.5.3. Product Benchmarking
10.5.4. Key Developments
10.6. NovaDel Pharma Inc.
10.6.1. Company Overview
10.6.2. Financial Overview
10.6.3. Product Benchmarking
10.6.4. Key Developments
10.7. Merck KGaA
10.7.1. Company Overview
10.7.2. Financial Overview
10.7.3. Product Benchmarking
10.7.4. Key Developments
10.8. Tokyo Chemical Industry Co.
10.8.1. Company Overview
10.8.2. Financial Overview
10.8.3. Product Benchmarking
10.8.4. Key Developments
10.9. Ceva Santé Animale S.A.
10.9.1. Company Overview
10.9.2. Financial Overview
10.9.3. Product Benchmarking
10.9.4. Key Developments
10.10. Kaiyuan Hengtai Chemical Co., Ltd.
10.10.1. Company Overview
10.10.2. Financial Overview
10.10.3. Product Benchmarking
10.10.4. Key Developments

11. Key Insights

Content are not available

Choose License Type